(Q38689894)

5 September 2017

title

Neoplasms derived from plasmacytoid dendritic cells (English)

1 reference

5 September 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Giuseppe Rossi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

William Vermi

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

5

Silvia Lonardi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

2

Marta Cigognetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

Simona Fisogni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

8 January 2016

1 reference

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

98-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26743477%20AND%20SRC:MED&resulttype=core&format=json

[Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes].

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cells and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Trafficking properties of plasmacytoid dendritic cells in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

The plasmacytoid monocyte/interferon producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Type I interferons: diversity of sources, production pathways and effects on immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Human and Mouse Mononuclear Phagocyte Networks: A Tale of Two Species?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cells: recent progress and open questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Plasmacytoid dendritic cells: physiologic roles and pathologic states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Novel markers of normal and neoplastic human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Acute agranular CD4-positive natural killer cell leukemia. Comprehensive clinicopathologic studies including virologic and in vitro culture with inducing agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

BAD-LAMP is a novel biomarker of nonactivated human plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation--a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

What is CD4+CD56+ malignancy and how should it be treated?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Clinical and biologic features of CD4+CD56+ malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Gene-expression profiling and array-based CGH classify CD4+CD56+ hematodermic neoplasm and cutaneous myelomonocytic leukemia as distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

Cutaneous Manifestations of Blastic Plasmacytoid Dendritic Cell Neoplasm—Morphologic and Phenotypic Variability in a Series of 33 Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2015.145

CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype

21 January 2018

1 reference

12 December 2020

The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies

1 reference

12 December 2020

In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response

1 reference

12 December 2020

[Pseudofollicular nests of plasmacells (of a special type?) in paracortical pulp of human lymph nodes (author' s transl)]

1 reference

12 December 2020

Blastic natural killer cell leukemia/lymphoma: a clinicopathologic study

1 reference

12 December 2020

Leukemic plasmacytoid dendritic cells share phenotypic and functional features with their normal counterparts

1 reference

12 December 2020

Blastic plasmacytoid dendritic cell neoplasm: the first report of two cases treated by 5-Azacytidine

1 reference

12 December 2020

CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Francais de Cytogenetique Hematologique

1 reference

12 December 2020

BDCA-2 (CD303): a highly specific marker for normal and neoplastic plasmacytoid dendritic cells.

1 reference

12 December 2020

Tumor-forming plasmacytoid dendritic cells associated with myeloid neoplasms. Report of a peculiar case with histopathologic features masquerading as lupus erythematosus.

1 reference

12 December 2020

Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization

1 reference

12 December 2020

Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer.

1 reference

12 December 2020

CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)

1 reference

12 December 2020

Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms

1 reference

12 December 2020

In vivo generation of human dendritic cell subsets by Flt3 ligand

1 reference

12 December 2020

Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell

1 reference

12 December 2020

CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon

1 reference

12 December 2020

Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin

1 reference

12 December 2020

Stem cell transplantation can provide durable disease control in blastic plasmacytoid dendritic cell neoplasm: a retrospective study from the European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

TET2 and TP53 mutations are frequently observed in blastic plasmacytoid dendritic cell neoplasm

1 reference

12 December 2020

TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis

1 reference

12 December 2020

Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia

1 reference

12 December 2020

Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients

1 reference

12 December 2020

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology

1 reference

12 December 2020

Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm

1 reference

12 December 2020

Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?

1 reference

12 December 2020

CD123 hiDendritic Cell Lymphoma: An Unusual Case of Non-Hodgkin Lymphoma

1 reference

12 December 2020

Plasmacytoid T cells: a cell population normally present in the reactive lymph node. An immunohistochemical and electronmicroscopic study

1 reference

12 December 2020

'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes

1 reference

12 December 2020

CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia

1 reference

12 December 2020

Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage

1 reference

12 December 2020

CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells.

1 reference

12 December 2020

Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases

1 reference

12 December 2020